[en] Abstract
The association of primary sclerosing cholangitis (PSC)
and autoimmune hepatitis (AIH) is known as an overlap
syndrome (OS). OS can also be described in the
setting of concomitant presence of AIH and PSC. These
diseases can in some cases be associated with ulcerative
colitis. In this case report we describe, to our
knowledge, the first case in the literature of a young
Caucasian male suffering from ulcerative colitis and an
overlap syndrome consisting of an association between
PSC-AIH, with the concomitant presence of a membranous
glomerulonephritis.
Rust C, Beuers U. Overlap syndromes among autoimmune liver diseases. World J Gastroenterol 2008; 14: 3368-3373 [PMID: 18528934 DOI: 10.3748/wjg.14.3368]
Czaja AJ. Difficult treatment decisions in autoimmune hepatitis. World J Gastroenterol 2010; 16: 934-947 [PMID: 20180231 DOI: 10.3748/wjg.v16.i8.934]
Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 2011; 54: 374-385 [PMID: 21067838 DOI: 10.1016/j.jhep.2010.09.002]
Culver EL, Chapman RW. Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis. Aliment Pharmacol Ther 2011; 33: 1273-1291 [PMID: 21501198 DOI: 10.1111/j.1365-2036.2011.04658.x]
Floreani A, Rizzotto ER, Ferrara F, Carderi I, Caroli D, Blasone L, Baldo V. Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol 2005; 100: 1516-1522 [PMID: 15984974 DOI: 10.1111/j.1572-0241.2005.41841.x]
Kaya M, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. J Hepatol 2000; 33: 537-542 [PMID: 11059857 DOI: 10.1016/S0168-8278(00)80004-5]
Boberg KM, Fausa O, Haaland T, Holter E, Mellbye OJ, Spurkland A, Schrumpf E. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology 1996; 23: 1369-1376 [PMID: 8675153 DOI: 10.1002/ hep.510230612]
Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Meyer zum Büschenfelde KH, Zeniya M. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938 [PMID: 10580593 DOI: 10.1016/S0168-8278(99)80297-9]
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51: 237-267 [PMID: 19501929 DOI: 10.1016/j.jhep.2009.04.009]
Navaneethan U, Venkatesh PG, Lashner BA, Shen B, Kiran RP. The Impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis. Aliment Pharmacol Ther 2012; Epub ahead of print[PMID: 22428605 DOI: 10.1111/j.1365-2036.2012.05063.x]
Pongpaibul A, Venick RS, McDiarmid SV, Lassman CR. Histopathology of de novo autoimmune hepatitis. Liver Transpl 2012; 18: 811-818 [PMID: 22378542 DOI: 10.1002/lt.23422]
Abraham SC, Freese DK, Ishitani MB, Krasinskas AM, Wu TT. Significance of central perivenulitis in pediatric liver transplantation. Am J Surg Pathol 2008; 32: 1479-1488 [PMID: 18708942 DOI: 10.1097/PAS.0b013e31817a8e96]
Saich R, Chapman R. Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease. World J Gastroenterol 2008; 14: 331-337 [PMID: 18200656 DOI: 10.3748/wjg.14.331]
Beuers U, Rust C. Overlap syndromes. Semin Liver Dis 2005; 25: 311-320 [PMID: 16143946 DOI: 10.1055/s-2005-916322]
Pardi DS, Tremaine WJ, Sandborn WJ, McCarthy JT. Renal and urologic complications of inflammatory bowel disease. Am J Gastroenterol 1998; 93: 504-514 [PMID: 9576439 DOI: 10.1111/j.1572-0241.1998.156_b.x]
Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, Lakatos PL. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year followup study. World J Gastroenterol 2003; 9: 2300-2307 [PMID: 14562397]
Casella G, Perego D, Baldini V, Monti C, Crippa S, Buda CA. A rare association between ulcerative colitis (UC), celiac disease (CD), membranous glomerulonephritis, leg venous thrombosis, and heterozygosity for factor V Leiden. J Gastroenterol 2002; 37: 761-762 [PMID: 12375154 DOI: 10.1007/ s005350200126]
Makhlough A, Fakheri H. Membranous glomerulonephritis associated with ulcerative colitis. Iran J Kidney Dis 2008; 2: 102-104 [PMID: 19377218]
Dhiman RK, Poddar U, Sharma BC, Arora P, Saraswat VA, Pandey R, Naik SR. Membranous glomerulonephritis in association with ulcerative colitis. Indian J Gastroenterol 1998; 17: 62 [PMID: 9563224]
Ridder RM, Kreth HW, Kiss E, Gröne HJ, Gordjani N. Membranous nephropathy associated with familial chronic ul- cerative colitis in a 12-year-old girl. Pediatr Nephrol 2005; 20: 1349-1351 [PMID: 15971070 DOI: 10.1007/s00467-005-1986-6]
Regéczy N, Lakos G, Balogh I, Kappelmayer J, Kiss E. Membranous glomerulonephritis in a patient with inherited activated protein C resistance. Clin Nephrol 2000; 53: 390-393 [PMID: 11305813]
Verresen L, Waer M, Verberckmoes R, Morias P, Michielsen P. Primary sclerosing cholangitis associated with membranous nephropathy. Ann Intern Med 1988; 108: 909-910 [PMID: 3369788 DOI: 10.7326/0003-4819-108-6-909_2]
Stefanidis I, Giannopoulou M, Liakopoulos V, Dovas S, Karasavvidou F, Zachou K, Koukoulis GK, Dalekos GN. A case of membranous nephropathy associated with Sjögren syndrome, polymyositis and autoimmune hepatitis. Clin Nephrol 2008; 70: 245-250 [PMID: 18793567 DOI: 10.5414/ CNP70245]
Takahashi K, Takasaki S, Morita C, Hayashida K, Matsui M, Tamechika Y, Ishibashi H. Autoimmune hepatitis with membranous glomerulonephritis. J Gastroenterol Hepatol 2001; 16: 356-359 [PMID: 11339433 DOI: 10.1046/ j.1440-1746.2001.02345.x]
Wilcox GM, Aretz HT, Roy MA, Roche JK. Glomerulonephritis associated with inflammatory bowel disease. Report of a patient with chronic ulcerative colitis, sclerosing cholangitis, and acute glomerulonephritis. Gastroenterology 1990; 98: 786-791 [PMID: 2137104]
Oikonomou K, Kapsoritakis A, Eleftheriadis T, Stefanidis I, Potamianos S. Renal manifestations and complications of inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 1034-1045 [PMID: 20842645 DOI: 10.1002/ibd.21468]
Oikonomou KA, Kapsoritakis AN, Stefanidis I, Potamianos SP. Drug-induced nephrotoxicity in inflammatory bowel disease. Nephron Clin Pract 2011; 119: c89-94; discussion c96 [PMID: 21677443 DOI: 10.1159/000326682]
Firwana BM, Hasan R, Chalhoub W, Ferwana M, Kang JY, Aron J, Lieber J. Nephrotic syndrome after treatment of Crohn's disease with mesalamine: Case report and literature review. Avicenna J Med 2012; 2: 9-11 [PMID: 23210014 DOI: 10.4103/2231-0770.94804]
Gisbert JP, González-Lama Y, Maté J. 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis 2007; 13: 629-638 [PMID: 17243140 DOI: 10.1002/ibd.20099]
Hofstra JM, Beck LH, Beck DM, Wetzels JF, Salant DJ. Antiphospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2011; 6: 1286-1291 [PMID: 21474589 DOI: 10.2215/ CJN.07210810]